-
When one decides to start a drug therapy in patients affected by type 2 diabetes, in general metphormin is prescribed or (in the USA) a glitazone. Some researchers have compared these two choices through a double-blinded randomized study using rosiglitazone. The study, sponsored by pharmaceutical [...]
-
The American Diabetes Association (ADA) established in 2002 the indications to perform type-2 diabetes screening in children: these indications include more than 10 years of age, overweight (BMI > 85° centile) and one of the following factors: diabetes familiarity, particular ethnicity (American [...]
-
According to Diabetes Prevention Program, a drastic intervention on the lifestyle of obese patients with impaired glucose tolerance has decreased the incidence of diabetes mellitus in the following three years compared to the normal management of these subjects. Afterwards, researchers have tried [...]
-
According to the Diabetes Prevention Program, an intensive intervention on the lifestyle of overweight patients with an impaired glucose tolerance is able to lower the incidence of new cases of type 2 diabetes mellitus. In this further analysis, researchers tried to determine which is the lifestyle [...]
-
Many type-2 diabetic, even if their glycemic profile is well controlled and they do not use insulin, have the habit to self-measure glycemia, so researchers wondered whether these home measurements can really help to keep a better metabolic compensation. Then an observational trial was performed in [...]
-
(ASPEN Trial: Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in Non-Insulin-Dependent Diabetes Mellitus)
Diabetes represents a cardiovascular risk, so in a diabetic it is essential to try to decrease other possible risk factor. In a multicentric trial, [...]
-
When one has to select patients destined to a preventive therapy to decrease the coronary risk, the presence of diabetes mellitus is equalled to a previous cardiac ischemic episode. Studies which led to consider diabetes as a separate cardiovascular risk factor are by now many. But most of these [...]
-
It has been recently approved an insulin with a rapid action, administrable via inhalation, whose marketing should be forthcoming. Some studies have shown his efficacy similar to those of oral drug in type 2 diabetes, even if burdened by a greater risk of hypoglycemia. A study sponsored by [...]